Abstract
Clarifying the role of the TSH receptor protein in the autoimmune process may be the key to understanding the development of Graves’ disease. In the present study we used a 16 amino acid peptide of the human TSH receptor (hTSHR) to immunize rabbits. A comparable, but theoretically less immunogenic, peptide was injected into other rabbits. The antibody response against these and other peptides, as well as against solubilized human thyroid membrane (TM) and guinea pig fat cell membrane (GPF) proteins, was tested using ELISA and Western blots. The GPF and TM binding pattern of rabbits’ sera was compared to that of Graves’ patients’ sera. We have identified an area of antigenic cross-reactivity between GPF and TM; a 63 kD protein was present in both GPF and TM, and this protein uniformly bound IgG-s of the rabbits’ postimmunization sera and one of eight Graves’ patient’s serum. We have shown that i) a theoretically immunogenic 16 amino acid peptide was indeed highly immunogenic in rabbits, ii) antibodies binding to GPF and TM were detected after immunization, and iii) the peak of thyroid stimulating immunoglobulin activity of sera was followed by a transient elevation of serum triiodothyronine levels. Further studies investigating the immunogenic epitopes of the hTSHR as well as characterizing the 63 kD protein are indicated.
Similar content being viewed by others
References
McKenzie J.M. Humoral factors in the pathogenesis of Graves’ disease. Physiol. Rev. 43: 252, 1968.
Burman, K.D., Baker J.R.Jr. Immune Mechanisms in Graves’ Disease. Endocr. Rev. 6: 183, 1985.
Yavin E., Schneider M.D., Kohn L.D. Monoclonal antibodies to the thyrotropin receptor: implications for receptor structure and the action of autoantibodies in Graves’ disease. Proc. Natl. Acad. Sci. USA 78: 3180, 1981.
Kyle J., Doolittle R.F. A simple method for displaying the hydropathic nature of a protein. J. Molec. Biol. 157: 105, 1982.
McFarland K.C., Sprengel R., Phillips H.S., Kohler M., Rosemblit N., Nikolics K., Segaloff D.L., Seeburg P.H. Lutropin-choriogonadotropin receptor: an unusual member of the G protein-coupled receptor family. Science 245: 494, 1989.
Loosfelt H., Misrahi M., Atger M., Salesse R., Thi M.T.V.H.L., Jolivet A., Guiochon-Mantel A., Sar S., Jallal B., Gamier J., Milgrom E. Cloning and sequencing of porcine LH-hCG receptor cDNA: variants lacking transmembrane domain. Science 245: 525, 1989.
Wadsworth H.L., Chazenbalk G.D., Nagayama Y., Russo D., Rapoport B. An insertion in the human thyrotropin receptor critical for high affinity hormone binding. Science 249: 1423, 1990.
Misrahi M., Loosfelt H., Atger M., Sar S., Guiochon-Mantel A., Milgrom E. Cloning, sequencing and expression of human TSH receptor. Biochem. Biophys. Res. Commun. 166: 394, 1990.
Nagayama Y., Kaufman K.D., Seto P., Rapoport B. Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. Biochem. Biophys. Res. Commun. 165: 1184, 1989.
Libert F., Lefort A., Gerard C., Paramentier M., Perret J., Ludgate M., Dumont J.E., Vassart G. Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. Biochem. Biophys. Res. Commun. 165: 1250, 1989.
Parmentier M., Libert F., Maenhaut C., Lefort A., Gerard C., Perret J., Van S.J., Dumont J.E., Vassart G. Molecular cloning of the thyrotropin receptor. Science 246: 1620, 1989.
Akamizu, T., Ikuyama S., Saji M., Kosugi S., Kozak C., McBride O.W., Kohn L.D. Cloning, chromosomal assignment, and regulation of the rat thyrotropin receptor: expression of the gene is regulated by thyrotropin, agents that increase cAMP levels, and thyroid autoantibodies. Proc. Natl. Acad. Sci. USA 87: 5677, 1990.
Burch H.B., Nagy E.V., Lukes Y.G., Cai W.Y., Wartofsky L., Burman K.D. Nucleotide and amino acid homology between the human thyrotropin receptor and the HIV-1 Nef protein: Identification and functional analysis. Biochem. Biophys. Res. Commun. 181: 498, 1991.
Merrifield R.B. Solid phase peptide synthesis I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 85: 2149, 1963.
Houghten R.A., Bray M.K., DeGraw ST., Kirby C.J. Simplified procedure for carrying out simultaneous multiple hydrogen fluoride cleavage of protected peptide resins. Int. J. Pept. Protein. Res. 27: 673, 1985.
Baker J.R.Jr., Lukes Y.G., Smallridge R.C., Berger M., Burman K.D. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotropin binding sites in guinea pig fat cell membranes (Development of a direct immunoassay). J. Clin. Invest. 72: 1487, 1983.
Baker J.R.Jr., Saunders N.B., Kaulfersch W., Burman K.D. The development of human monoclonal antibodies from Graves’ disease patients which demonstrate the ability to inhibit TSH-mediated production of cyclic-adenosine monophosphate in thyrocytes. J. Immunol. 140: 2593, 1988.
Mamula M.J. The inability to process a self-peptide allows autoreactive T cells to escape tolerance. J. Exp. Med. 177: 567, 1993.
Heyma P., Harrison L.C. Immunoprecipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves’ disease immunoglobulins. J. Clin. Invest. 74: 1090, 1984.
Rapoport B., Seto P., Magnusson R.P. Immunoprecipitation of radiolabelled human thyroid cell proteins by serum from patients with autoimmune thyroid disease. Endocrinology 115: 2137, 1984.
Ealey P.A., Valentine W.A., Ekins R.P., Kohn L.D., Marshal N.J. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cyto-chemical bioassay for thyroid stimulators. Endocrinology 116: 124, 1985.
McQuade R., Thomas C.G., Nayfeh S.N. Further characterization of the low and high affinity binding components of the thyrotropin receptor. Biochem. Biophys. Res. Commun. 137: 61, 1986.
Bartalena L., Fenzi G., Vitti P., Tombaccini D., Antonelli A., Macchia E., Chiovato L., Kohn L.D., Pinchera A. Interaction of the thyrotropin receptor on rat FRTL-5 thyroid cells with thyrotropin and thyrotropin-stimulating autoantibody from Graves’ patients. Biochem. Biophys. Res. Commun. 143: 266, 1987.
Gennick S.E., Thomas C.G.Jr., Nayfeh S.N. Characterization of the subunit structure of the thyrotropin receptor in the FRTL-5 rat thyroid cell line. Endocrinology 121: 2119, 1987.
Leedman J.P., Newman J.D., Harrison L.C. Human thyrotropin receptor subunits characterized by thyrotropin affinity purification and Western blotting. J. Clin. Endocrinol. Metab. 69: 134, 1989.
Salvi M., Bernard N., Miller A., Zhang Z., Gardini E., Wall J.R. Prevalence of antibodies reactive with a 64 kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy. Thyroid 1: 207, 1991.
Weetman A.P., Nutman T.B., Burman K.D., Baker J.R.Jr., Volkman D.J. Heterogeneity of thyroid autoantigens identified by immunoblotting. Clin. Immunol. Immunopathol. 43: 333, 1987.
Dong Q., Ludgate M.,. Vassart G. Cloning and sequencing of a novel 64 kDa autoantigen recognized by patients with autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 72: 1375, 1991.
Endo T., Ohmori M., Ikeda M., Kotani S., Onaya T. Rabbit antibodies against two different extracellular domains of human thyrotropin receptor possess thyroid stimulating antibodies. Biochem. Biophys. Res. Commun. 179: 1548, 1991.
Mori T., Sugawa H., Piraphatdist T., Inoue D., Enomoto T., Imura H. A synthetic oligopeptide derived from human thyrotropin receptor sequence binds to Graves’ immunoglobulin and inhibits thyroid stimulating antibody activity but lacks interactions with TSH. Biochem. Biophys. Res. Commun. 178: 165, 1991.
Sakata S., Ogawa T., Matsui I., Manshouri T., Atassi M.Z. Biological activities of rabbit antibodies against synthetic human thyrotropin receptor peptides representing thyrotropin binding regions. Biochem. Biophys. Res. Commun. 182: 1369, 1992.
lida, Y., Amir S.M., Ingbar S.H. Stabilization, partial purification and characterization of thyrotropin receptor in solubilized guinea pig fat cell membranes. Endocrinology 121: 1627, 1987.
Nagy E.V., Burch H.B., Mahoney K., Lukes Y.G., Morris J.C., Burman K.D. Graves’ IgG recognizes linear epitopes in the human thyrotropin receptor. Biochem. Biophys. Res. Commun. 188: 28, 1992.
Takai O., Desai R.K., Seetharamaiah G.S., Jones CA., Allaway G.P., Akamizu T., Kohn L.D., Prabhakar B.S. Prokaryotic expression of the thyrotropin receptor and identification of an immunogenic region of the protein using synthetic peptides. Biochem. Biophys. Res. Commun. 179: 319, 1991.
Author information
Authors and Affiliations
Additional information
The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or reflecting the views of the Army or the Department of Defense.
Rights and permissions
About this article
Cite this article
Nagy, E.V., Burch, H.B., Lukes, Y.G. et al. Immunogenicity of a unique region of the human thyrotropin receptor. J Endocrinol Invest 16, 485–493 (1993). https://doi.org/10.1007/BF03348887
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348887